Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience

Open Access

Peer-reviewed

Research Article

Zsuzsanna Varga ,

* E-mail: zsuzsanna.varga@usz.ch

Affiliation Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland
⨯
Aurelia Noske

Affiliation Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland
⨯

Reader Comments (0)

Immunohistochemistry techniques
Is the Subject Area "Immunohistochemistry techniques" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Membrane staining
Is the Subject Area "Membrane staining" applicable to this article?

Thanks for your feedback.
Fluorescent in situ hybridization
Is the Subject Area "Fluorescent in situ hybridization" applicable to this article?

Thanks for your feedback.
Signal amplification
Is the Subject Area "Signal amplification" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Invasive tumors
Is the Subject Area "Invasive tumors" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.